RETROTOPE is a privately held company focused on the development of ways of controlling metabolic processes associated with the oxidative stress conditions. Areas of interest include age-related diseases. The company uses isotope effect to slow down damaging pathways. They have several discovery and development programs that involve major classes of biopolymers, with the major focus in neurological diseases such as Friedreich's ataxia.